Groupe Colipain SRL
Groupe Colipain reported total assets of 406,405 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026).
The score of Groupe Colipain shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +545 % Total assets -38 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Groupe Colipain's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 06 Oct 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 08 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Groupe Colipain's financial analysis
- Solvency24.9%sector median: 49.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Groupe Colipain
Groupe Colipain's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.707.211
- VAT number
- BE0474707211
- Peppol
- Registered · 0208:0474707211 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 May 2001
- Registered office
- 1440 Braine-le-Château
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Groupe Colipain (SRL) has been based in Braine-le-Château since 2001, active in: business and other management consultancy activities. For 2025, it reports a net profit of 25,200 € and equity of 101,260 €; its revenue is not published. Its solvency stands at 24.9%, below the median of its sector (49.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Groupe Colipain
Companies in the same business, of comparable size and area, outside its group.
- A.B.A. Invest Business and other management consultancy activities Eupen · balance sheet 462,944 €
- A2P Business and other management consultancy activities Tournai · balance sheet 556,235 €
- Good to Great Business and other management consultancy activities Bilzen-Hoeselt · balance sheet 366,717 €
- Avverde Business and other management consultancy activities Woluwe-Saint-Lambert · balance sheet 234,705 €
- Madison Consult Market research and public opinion polling Brussels · balance sheet 403,941 €
- Gaff Services Market research and public opinion polling Ghent · balance sheet 411,314 €
- Marcers Business and other management consultancy activities Ixelles · balance sheet 580,249 €
- CC Consulting Business and other management consultancy activities Roeselare · balance sheet 532,965 €
Frequently asked questions about Groupe Colipain
What is the revenue of Groupe Colipain?
Groupe Colipain files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Groupe Colipain?
In Belgium, the VAT number is the company number prefixed with BE: BE0474707211 for Groupe Colipain, if the company is VAT-registered. Its company number (CBE) is 0474.707.211.
Where is the registered office of Groupe Colipain?
According to the CBE register, the registered office of Groupe Colipain is in 1440 Braine-le-Château.
What is the equity of Groupe Colipain?
At the close of the 2025 financial year, the equity of Groupe Colipain amounts to 101,260 €, a solvency of 24.9% of total assets.
Who manages Groupe Colipain?
The register lists 1 active mandates at Groupe Colipain. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Groupe Colipain
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →